Searching for a career beyond the academy is a daunting task. After years (maybe even a decade) of working towards a degree of specialty within your field, you have undoubtedly developed expectations ...

In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other pharma stocks. Healthcare takes the concept of ‘defensive’ further than almost any ...

The Judicial Intern Opportunity Program (JIOP) is a full-time (six-week minimum) summer internship program open to diverse law students who want to do legal research and writing for state or federal ...

Pharmaceutical company AbbVie (ABBV) is the latest stock in my portfolio to announce a higher dividend. Accompanying its third-quarter earnings report, AbbVie declared a 5.8% increase in its ...

The AbbVie Foundation, a nonprofit dedicated to addressing health inequities, has made a $75 million donation to the University of Chicago to support the construction of UChicago Medicine’s new cancer ...

AbbVie is entering into a collaboration and option-to-license deal with EvolveImmune Therapeutics to develop biologics for multiple oncology targets. Connecticut-based EvolveImmune, which develops ...

AbbVie’s deal team is having a busy week. Days after inking a $1.4 billion buyout, the drugmaker has put up the same again in biobucks to secure options on multispecific T-cell engagers from ...

(RTTNews) - AbbVie (ABBV) and EvolveImmune Therapeutics announced a collaboration and option-to-license agreement to develop multispecific biologics for multiple targets in oncology. The ...

AbbVie has inked a deal to work with privately held immuno-oncology company EvolveImmune Therapeutics, to develop therapeutic antibodies for cancer. AbbVie on Thursday said EvolveImmune will ...

The new cancer treatment-and-research center will be named the AbbVie Foundation Cancer Pavilion. The University of Chicago has received a $75 million donation from the AbbVie Foundation to help ...